Ignite Creation Date:
2024-05-19 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06411002
Status:
RECRUITING
Last Update Posted:
2024-05-22
First Post:
2024-05-08
Brief Title:
Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
Sponsor:
Revance Therapeutics Inc
Organization:
Revance Therapeutics Inc
Organization Data
Organization:
Revance Therapeutics Inc
Class:
INDUSTRY
Study ID:
2320201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Revance Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None